Eagle Pharmaceuticals Inc. (EGRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE, NJ 07677
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments55,321102,971103,155109,77578,791114,657
Cash and cash equivalents55,32197,659103,155109,77578,791114,657
Short-term investments  5,312    
Receivables72,43941,14951,11748,00466,48653,821
Inventory, net of allowances, customer advances and progress billings47,79421,9088,0756,5668,3045,118
Inventory47,79421,9088,0756,5668,3045,118
Prepaid expense3481,3691914,8525,8899,713
Other current assets3,2593,1591,6051,445134561
Other undisclosed current assets9,5932,0501,9228,8074,2404,827
Total current assets:188,754172,606166,065179,449163,844188,697
Noncurrent Assets
Property, plant and equipment1,1681,6362,0772,2022,3976,820
Intangible assets, net (including goodwill)163,36050,41452,66055,32657,84663,065
Goodwill45,03339,74339,74339,74339,74339,743
Intangible assets, net (excluding goodwill)118,32710,67112,91715,58318,10323,322
Regulated entity, other noncurrent assets     6001,000
Deferred income tax assets27,14618,79815,18013,669
Other noncurrent assets25,73210,27817,2083,908694124
Other undisclosed noncurrent assets     13,22210,354
Total noncurrent assets:217,40681,12687,12575,10574,75981,363
TOTAL ASSETS:406,160253,732253,190254,554238,603270,060
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities104,83748,76930,08533,82333,43627,372
Accounts payable18,99316,4316,2685,4629,91711,981
Accrued liabilities85,84432,33823,81728,36123,51915,391
Debt6,25025,6078,0005,0006,2504,875
Business combination, contingent consideration, liability      15,055
Other undisclosed current liabilities      
Total current liabilities:111,08774,37638,08538,82339,68647,302
Noncurrent Liabilities
Long-term debt and lease obligation56,216 25,13533,55738,15542,905
Long-term debt, excluding current maturities56,216 25,13533,55738,15542,905
Liabilities, other than long-term debt5,2972,9033,9593,000 709
Other liabilities5,2972,9033,9593,000  
Business combination, contingent consideration, liability      709
Total noncurrent liabilities:61,5132,90329,09436,55738,15543,614
Total liabilities:172,60077,27967,17975,38077,84190,916
Equity
Equity, attributable to parent233,560176,453186,011179,174160,762179,144
Common stock181717171716
Treasury stock, value(243,115)(225,111)(203,898)(171,861)(153,900)(80,795)
Additional paid in capital366,265325,779305,403278,518256,458233,639
Accumulated other comprehensive loss(1,112)(94)    
Retained earnings111,50475,86284,48972,50058,18726,284
Total equity:233,560176,453186,011179,174160,762179,144
TOTAL LIABILITIES AND EQUITY:406,160253,732253,190254,554238,603270,060

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues316,610171,546187,802195,892213,312236,707
Revenue, net236,707
Cost of revenue
(Cost of Goods and Services Sold)
(85,458)(31,528)(33,647)(47,891)(42,374)(33,714)
Other undisclosed gross profit    (13,006)  
Gross profit:231,152140,018154,155134,995170,938202,993
Operating expenses(150,192)(137,249)(121,201)(126,186)(176,696)(162,717)
Other undisclosed operating income    13,00642,37433,714
Operating income:80,9602,76932,95421,81536,61673,990
Nonoperating income (expense)(19,527)(7,317)(10,277)183(2,578)(1,045)
Investment income, nonoperating2715605622,16915891
Other nonoperating income (expense)(15,753)(6,242)(8,262)700  
Interest and debt expense(4,444)(1,635)(2,577)(2,686)(2,736)(300)
Income (loss) from continuing operations before equity method investments, income taxes:56,989(6,183)20,10019,31231,30272,645
Other undisclosed income from continuing operations before income taxes4,4441,6352,5772,6862,736300
Income (loss) from continuing operations before income taxes:61,433(4,548)22,67721,99834,03872,945
Income tax expense(25,791)(4,079)(10,688)(7,685)(2,135)(21,002)
Income (loss) from continuing operations:35,642(8,627)11,98914,31331,90351,943
Income (loss) before gain (loss) on sale of properties:(8,627)11,98914,31331,90351,943
Net income (loss) available to common stockholders, diluted:35,642(8,627)11,98914,31331,90351,943

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):35,642(8,627)11,98914,31331,90351,943
Comprehensive income (loss):35,642(8,627)11,98914,31331,90351,943
Other undisclosed comprehensive loss, net of tax, attributable to parent(1,018)(94)    
Comprehensive income (loss), net of tax, attributable to parent:34,624(8,721)11,98914,31331,90351,943

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: